Form 4: PTC Therapeutics Director Gifts Shares
Insider Transaction Report
PTC Therapeutics Director Stephanie Okey reported a gift of 867 common shares to a charitable organization.
Summary
- Stephanie Okey, a Director at PTC Therapeutics, Inc. (PTCT), reported a transaction involving the company's common stock.
- On November 20, 2025, Okey gifted 867 shares of common stock to a charitable organization.
- The transaction was a bona fide gift, with a reported price of $0 per share.
- Following this gift, Okey directly beneficially owns 8,000 shares of PTC Therapeutics common stock.
Sentiment
Score: 5
Explanation: Neutral. This is a routine insider transaction (a gift) and does not inherently indicate positive or negative sentiment towards the company's performance or prospects.
Future Outlook
NA
Industry Context
This filing details a routine insider transaction and does not provide information relevant to broader industry trends or competitive analysis.
Stakeholder Impact
- Minor positive impact on the charitable organization receiving the shares.
- Minimal direct impact on shareholders, as it represents a small percentage of total outstanding shares and is a routine insider disclosure.
Key Dates
| Date | Description |
|---|---|
| 11/20/2025 | Date of the transaction where 867 shares of common stock were gifted. |
| 11/21/2025 | Signature date of the reporting person's attorney-in-fact for the filing. |
Keywords
PTC Therapeutics, PTCT, Stephanie Okey, Form 4, Insider Transaction, Stock Gift, Director, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.